Lingying Yu

1.5k total citations · 1 hit paper
29 papers, 986 citations indexed

About

Lingying Yu is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Lingying Yu has authored 29 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Lingying Yu's work include Natural product bioactivities and synthesis (8 papers), Pharmacological Effects of Natural Compounds (3 papers) and Ginger and Zingiberaceae research (3 papers). Lingying Yu is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Pharmacological Effects of Natural Compounds (3 papers) and Ginger and Zingiberaceae research (3 papers). Lingying Yu collaborates with scholars based in China, Germany and United States. Lingying Yu's co-authors include Zhimin Chen, C. Hu, Mingyue Ao, Ying Peng, Ting Luo, Yu Tang, Jiaqi Wang, Chunling Zhang, Linhong Fan and Chunling Zhang and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and RSC Advances.

In The Last Decade

Lingying Yu

27 papers receiving 963 citations

Hit Papers

Anti-Inflammatory Effects of Curcumin in the Inflammatory... 2021 2026 2022 2024 2021 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingying Yu China 12 354 248 166 128 121 29 986
Fardous F. El‐Senduny Egypt 20 462 1.3× 168 0.7× 158 1.0× 170 1.3× 104 0.9× 58 1.4k
Vineet Mittal India 17 334 0.9× 123 0.5× 138 0.8× 131 1.0× 159 1.3× 70 1.1k
I. M. Krishnakumar India 19 260 0.7× 238 1.0× 76 0.5× 116 0.9× 91 0.8× 50 906
Chau Ling Tham Malaysia 21 383 1.1× 128 0.5× 92 0.6× 98 0.8× 181 1.5× 93 1.3k
Gomaa Mostafa‐Hedeab Egypt 22 431 1.2× 79 0.3× 133 0.8× 119 0.9× 138 1.1× 68 1.3k
Kalyan C. Nagulapalli Venkata United States 15 436 1.2× 84 0.3× 136 0.8× 135 1.1× 162 1.3× 18 1.5k
Maria Chaudhry United States 9 543 1.5× 91 0.4× 174 1.0× 113 0.9× 169 1.4× 38 1.6k
Jing Yang China 21 650 1.8× 169 0.7× 155 0.9× 262 2.0× 161 1.3× 123 1.4k
Hsiu‐Chen Huang Taiwan 20 563 1.6× 98 0.4× 118 0.7× 118 0.9× 118 1.0× 50 1.4k
Mou-Tuan Huang United States 16 738 2.1× 290 1.2× 100 0.6× 213 1.7× 177 1.5× 21 1.7k

Countries citing papers authored by Lingying Yu

Since Specialization
Citations

This map shows the geographic impact of Lingying Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingying Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingying Yu more than expected).

Fields of papers citing papers by Lingying Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingying Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingying Yu. The network helps show where Lingying Yu may publish in the future.

Co-authorship network of co-authors of Lingying Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingying Yu. A scholar is included among the top collaborators of Lingying Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingying Yu. Lingying Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xing, Lu Chen, Ming Zeng, et al.. (2025). Pathogenic role and therapeutic targets of nuclear factor‑κB signaling pathway in cancer (Review). Oncology Letters. 30(6). 1–24.
2.
Luo, Jian, et al.. (2025). Research Progress of Traditional Chinese Medicine in Adjuvant Treatment of Type 1 Diabetes. Phytotherapy Research. 39(12). 5567–5603.
3.
Zhou, Ye, Jie Wu, C. Hu, et al.. (2024). Polypeptides from traditional Chinese medicine: Comprehensive review of perspective towards cancer management. International Journal of Biological Macromolecules. 260(Pt 1). 129423–129423. 10 indexed citations
4.
Wu, Jie, Ye Zhou, Lingying Yu, et al.. (2024). Tissue distribution of metabolites in Cordyceps cicadae determined by DESI-MSI analysis. Analytical and Bioanalytical Chemistry. 416(8). 1883–1906. 5 indexed citations
5.
Zhou, Ye, et al.. (2024). Current advances in the pain treatment and mechanisms of Traditional Chinese Medicine. Phytotherapy Research. 38(8). 4114–4139. 2 indexed citations
6.
Wu, Jie, Ye Zhou, Lingying Yu, et al.. (2023). Synergistic mechanism of stir-baked curcumae radix with vinegar in dysmenorrhea rats based on UPLC-Q-TOF/MS metabolomics. Journal of Pharmaceutical and Biomedical Analysis. 240. 115944–115944. 1 indexed citations
7.
Peng, Ying, et al.. (2023). Research progress on the treatment of epilepsy with traditional Chinese medicine. Phytomedicine. 120. 155022–155022. 23 indexed citations
8.
Li, Xing, et al.. (2023). Anticancer perspective of 6-shogaol: anticancer properties, mechanism of action, synergism and delivery system. Chinese Medicine. 18(1). 138–138. 13 indexed citations
9.
Ye, Zhongfeng, et al.. (2022). Molecular characterization of a profilin gene from a parasitic ciliate Cryptocaryon irritans. Experimental Parasitology. 236-237. 108248–108248. 2 indexed citations
10.
11.
Ao, Mingyue, et al.. (2022). Polysaccharides from Chinese materia medica: Perspective towards cancer management. International Journal of Biological Macromolecules. 224. 496–509. 18 indexed citations
12.
Yu, Lingying, et al.. (2022). Radiofrequency Ablation of Parathyroid Glands to Treat a Patient With Hypercalcemia Caused by a Novel Inactivating Mutation in CaSR. Frontiers in Endocrinology. 12. 743517–743517. 3 indexed citations
13.
Peng, Ying, et al.. (2021). Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Design Development and Therapy. Volume 15. 4503–4525. 480 indexed citations breakdown →
14.
Chen, Zhimin, et al.. (2020). Different Processed Products of Curcumae Radix Regulate Pain-Related Substances in a Rat Model of Qi Stagnation and Blood Stasis. Frontiers in Pharmacology. 11. 242–242. 21 indexed citations
15.
Zhang, Chunling, Ting Luo, Jiaqi Wang, et al.. (2019). Limonin: A Review of Its Pharmacology, Toxicity, and Pharmacokinetics. Molecules. 24(20). 3679–3679. 113 indexed citations
16.
17.
Zhou, Li, Caiwei Wang, Rongrong Wang, et al.. (2018). Intra-Articular Injection of Fructus Ligustri Lucidi Extract Attenuates Pain Behavior and Cartilage Degeneration in Mono-Iodoacetate Induced Osteoarthritic Rats. Frontiers in Pharmacology. 9. 1360–1360. 10 indexed citations
18.
Yu, Lingying, et al.. (2015). Clinical significance of BRAF V600E mutation in 154 patients with thyroid nodules. Oncology Letters. 9(6). 2633–2638. 9 indexed citations
19.
Ma, Lizhen, et al.. (2015). Combined 17α-hydroxylase/17,20-lyase deficiency with short stature: case study. Gynecological Endocrinology. 32(4). 264–266. 3 indexed citations
20.
Feng, Liang, C. Hu, & Lingying Yu. (2010). [Pharmacokinetics of ginsenosides Rg1 and its metabolites in rats].. PubMed. 45(5). 636–40. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026